Company intelligence / Profile preview

Indivior

Chesterfield, Virginia, United Statesindivior.com ↗

Ownership: Public · INDV
Employees: ~1030
Development stage: Commercial

Overview

Indivior has developed and commercialized several leading treatments for opioid dependence, including Suboxone (buprenorphine/naloxone), Subutex (buprenorphine), Sublocade (extended-release buprenorphine injection), and OPVEE nasal spray. The company’s portfolio addresses opioid use disorder with both daily oral and monthly injectable options. Recent clinical advances include label expansions for Sublocade to support rapid initiation protocols.[1][5]

Therapeutic areas: Psychiatry
Modalities: Small molecules (notably buprenorphine and naloxone formulations)[1][5]
Industry: Biotech

Drug pipeline

11 assets

buprenorphine

Approved

10 more assets in the full pipeline.

Request access →

Partnerships

Co-development agreement with AntiOp, Inc. for a naloxone nasal spray product; licensing agreements for schizophrenia treatment distribution in Canada.[4] Also contracts with U.S. Biomedical Advanced Research and Development Authority for OPVEE supply.[5]

Financials

Market cap: $4.3B
Total revenue: $343M
Enterprise value: $4.6B

Beyond the preview

Go deeper on Indivior.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indivior.

Explore the full profile